Detect and monitor cancers such as canine hemangiosarcoma and lymphoma

VDxI-TK is a canine blood test utilizing the biomarker thymidine kinase

Clinical studies have demonstrated a significant elevation of TK levels in dogs with hemangiosarcoma and lymphoma. Click on "FAQ's" for more information. For more detail information on how to utilize this test, please review the CANCER section under EDUCATION.

A breakthrough in the diagnosis of clinically important infections such as sepsis

VDxI-pCNP is a simple blood test that measures canine NT-proCNP .

VDxI-pCNP will determine if the inflammatory response is due to a clinically important and often hidden infection, thus helping to prevent delayed or inappropriate treatment for a patient in distress. The biomarker pCNP has a high specificity (0.94) in detecting infection whereas current tests such as WBC “indicate that a wide variety of diseases are associated with neutrophilia and leukocytosis in dogs”¹. VDxI-pCNP is immediately available for dogs as the feline test validation process continues.

For more information on how to use pCNP, click here .

^1. Lucroy MD, Madewell, BR. Clinical outcome and associated diseases in dogs with leukocytosis and neutrophilia: 118 cases (1996-1998). JAVMA, Vol 214, No. 6, March 15, 1999